Hypertension: Commonly Used Drugs Risk Heart
Hypertension Drug Interactions with ACE2 Enzyme Under Scrutiny
Table of Contents
- Hypertension Drug Interactions with ACE2 Enzyme Under Scrutiny
- Hypertension Drug Interactions & ACE2: Your Questions Answered
- Q&A: Unpacking Hypertension Drug Interactions with ACE2
- Q: What’s the big deal about ACE2 and blood pressure?
- Q: What are ACE inhibitors and ARBs, and how do they work?
- Q: So, how does this new research change what we know about thes drugs?
- Q: Which specific medications are of concern?
- Q: Are there any potentially “safer” alternatives?
- Q: Which ACE inhibitor specifically, showed less impact?
- Q: What’s the deal with ARBs? They seem more complex.
- Q: What does this mean for me, and should I change my medication?
- Q: what are the future directions in hypertension treatment?
- Q: Where can I find more information or follow this research?
- Q&A: Unpacking Hypertension Drug Interactions with ACE2
Cardiovascular disease remains the leading cause of death globally, with arterial hypertension affecting over 1 billion people. While effective treatments exist,many individuals struggle to manage their blood pressure despite using common medications such as ACE inhibitors and angiotensin receptor blockers (ARBs).
A recent study published in Hypertension Research by researchers at the Penn School of Dental Medicine and the Perelman School of Medicine, raises questions about how these drugs interact with the ACE2 enzyme, known for its protective role in the cardiovascular system.
ACE2’s Crucial Role in Blood Pressure Regulation
The ACE2 enzyme converts Angiotensin II,a potent vasoconstrictor,into Angiotensin 1-7,a molecule that promotes vasodilation and lowers blood pressure. this process helps maintain balance within the renin-angiotensin system (RAS), which is vital for blood pressure control.
According to professor Henry Daniell, a study author, ACE2 is a key metabolic enzyme regulating hypertension and heart disease. He noted that direct interactions between antihypertensive drugs and ACE2 activity had not been thoroughly investigated until now.
Study on Canines Reveals Surprising Drug interactions
Researchers tested a novel oral formulation of ACE2, delivered via vegetable engineering (encapsulated in lettuce leaves), on dogs with mitral valvulopathy and hypertension already receiving ACE inhibitors and ARBs.
The study revealed two unexpected findings. First, ACE inhibitors appeared to reduce the activity of the administered ACE2, potentially negating its beneficial effects. Second, arbs seemed to increase Angiotensin II levels, which could be counterproductive without proper ACE2 activation.
These unexpected pharmacological reactions raise concerns about the mechanisms of action of current hypertension treatments. Daniell stated that effective blood pressure management requires avoiding ACE2 inhibition and preventing increases in angiotensin II.
Lisinopril Shows Less ACE2 Inhibition
The study indicated that not all ACE inhibitors behave identically. Lisinopril, a commonly prescribed ACE inhibitor in the United States, inhibited ACE2 activity significantly less than other drugs in its class. This variability could have crucial clinical implications, particularly for future combination therapies.
Daniell also noted the meaning of ACE2 activity, drawing a parallel to its interaction with the virus responsible for the COVID-19 pandemic. He expressed surprise at the similar levels of inhibition observed in both cases.
Drugs of Concern
Based on the study and existing research,the following medications warrant further investigation regarding their potential negative effects on ACE2 or the RAS balance:
ACE Inhibitors (Potential ACE2 Inhibitors):
- Enalapril (Vasotec)
- Ramipril (Triatec)
- Perindopril (Coversyl)
- Zofenopril (Bifril) – Not directly tested in the study,but belonging to the class
- Fosinopril (Fosinil)
ARBs (Potential Angiotensin II Production Activators):
- Losartan (Cozaar)
- Candesartan (Atacand)
- Telmisartan (Micardis)
- Olmesartan (Benicar) – Not directly tested in the study,but belonging to the class
Potentially Safer Alternatives
The study suggests that some drugs may interfere less with ACE2 or offer a more balanced mechanism of action. These include:
ACE Inhibitor with Less ACE2 Inhibition:
- Lisinopril (Zestril, Prinivil)
ARBs Requiring Cautious Use:
- Current data do not specify clear differences between ARBs. Further studies are needed to determine if Olmesartan, for example, has a more moderate impact than others.
Future Directions: A New Class of Treatments?
Looking ahead, researchers plan to conduct clinical trials in humans to assess the effects of vegetable-derived ACE2, following FDA authorization. The ultimate goal is to develop effective and affordable treatments that avoid the interferences observed with current medications.
Daniell said the aim is to make high-potential biological drugs accessible at a low cost for common conditions like hypertension and diabetes.
Hypertension Drug Interactions & ACE2: Your Questions Answered
High blood pressure, or hypertension, affects millions worldwide. Managing it effectively is crucial for overall health. Recent research sheds light on potential interactions between common hypertension medications and a key enzyme called ACE2. Let’s dive in and explore what this means for your health.
Q&A: Unpacking Hypertension Drug Interactions with ACE2
Q: What’s the big deal about ACE2 and blood pressure?
A: The ACE2 enzyme plays a crucial, protective role in regulating blood pressure. It converts Angiotensin II, a substance that raises blood pressure, into Angiotensin 1-7, which actually lowers blood pressure. This balance within the renin-angiotensin system (RAS) is vital for keeping your blood pressure in check, and keeping your heart healthy.
Q: What are ACE inhibitors and ARBs, and how do they work?
A: ACE inhibitors (Angiotensin-Converting Enzyme inhibitors) and ARBs (Angiotensin II Receptor Blockers) are two common classes of medications used to treat hypertension.
- ACE inhibitors, like Enalapril and Lisinopril, work by blocking the enzyme ACE, which prevents the conversion of Angiotensin I to Angiotensin II. With less Angiotensin II,your blood vessels relax,lowering blood pressure.
- ARBs, such as Losartan and Candesartan, block the action of Angiotensin II by preventing it from binding to its receptors.This also leads to blood vessel relaxation and lower blood pressure.
Q: So, how does this new research change what we know about thes drugs?
A: A recent study, published in Hypertension Research, suggests that some ACE inhibitors and ARBs might interact with ACE2 in unexpected ways. The study,conducted on dogs,found that:
- ACE Inhibitors: Some may reduce ACE2 activity,possibly diminishing its beneficial effects.
- ARBs: May increase Angiotensin II levels,which could be counterproductive,especially if ACE2 is not functioning optimally.
These findings raise concerns about the effectiveness of some current hypertension treatments and highlight the complex relationship between these medications and the body’s natural regulatory systems.
Q: Which specific medications are of concern?
A: Based on the study and other existing research, here’s a breakdown of medications that deserve further investigation:
| Medication Class | Medications of Concern | key Concerns |
|---|---|---|
| ACE Inhibitors |
|
Potential to inhibit ACE2 activity. |
| ARBs |
|
Potential to increase angiotensin II levels. |
Q: Are there any potentially “safer” alternatives?
A: The study suggests that some drugs may offer a more balanced approach,potentially interfering less with ACE2. Though, more research is crucial.
Q: Which ACE inhibitor specifically, showed less impact?
A: The study suggested that lisinopril (Zestril, Prinivil) inhibited ACE2 activity significantly less than other ACE inhibitors tested. This means that it may be a more favorable option, but definitely work with your doctor to determine the best course moving forward.
Q: What’s the deal with ARBs? They seem more complex.
A: The data currently regarding ARBs does not differentiate significantly between them. More studies are necessary to ascertain whether, as an example, Olmesartan has a comparatively moderate impact compared to other ARBs.
Q: What does this mean for me, and should I change my medication?
A: Do not change your medication without consulting your doctor! Discuss your concerns with your healthcare provider. They can assess your individual health profile, consider your current medications, and advise you on the best course of action. This research highlights the complexity of blood pressure management, but it does not mean a blanket change to medication is needed for all patients. This study requires future research!
Q: what are the future directions in hypertension treatment?
A: Researchers are exploring new treatment avenues. they plan to conduct human clinical trials to assess vegetable-derived ACE2, aiming to develop effective and affordable treatments that avoid the potential negative interactions observed with current medications. The goal is to make high-potential biological drugs accessible and affordable for common conditions like hypertension and diabetes.
Q: Where can I find more information or follow this research?
A: Check out peer-reviewed journals like “Hypertension Research”. Consult your doctor and ask to be referred to a cardiologist if you have high blood pressure!
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with your healthcare provider for any health concerns or before making any decisions related to your treatment.